BioLife Solutions is a Bothell, Washington-based life sciences tools and biomanufacturing company that acts as a corporate strategic investor. It deploys capital into strategically relevant cell and gene therapy manufacturing infrastructure and enabling technologies, including biopreservation media, cell processing, storage systems and closed-system manufacturing solutions. Its documented investing includes debt and early-stage venture financing in the United States, making it most relevant for biotechnology, life sciences, manufacturing and medical device companies aligned with advanced therapy supply chains.